Kovitz Investment Group Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,907
Closed -$260K 1277
2024
Q4
$260K Buy
+1,907
New +$260K ﹤0.01% 1079